Gerresheimer : Presentation 1st Quarter 2021

Q1 2021 Results Presentation

Dietmar Siemssen, CEO

Bernd Metzner, CFO

Duesseldorf, April 8, 2021

Disclaimer

• This presentation may contain certain forward-looking statements, including assumptions, opinions and views of the Company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or performance of the Company to differ materially from the estimations expressed or implied herein.
• The Company does not guarantee that the assumptions underlying such forward-looking statements are free from errors nor does the Company accept any responsibility for the future accuracy of the opinions expressed in this presentation or the actual occurrence of the forecast development.
• No representation or warranty (express or implied) is made as to, and no reliance should be placed on, any information, including projections, estimates, targets and opinions, contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and, accordingly, none of the Company or any of its parent or subsidiary undertakings or any of such person's officers, directors or employees accepts any liability whatsoever arising directly or indirectly from the use of this document.

2

08/04/2021

Q1 2021 Earnings Presentation

Achieving our Targets as One Gerresheimer

CEO Dietmar Siemssen

Accelerating Growth Momentum

Key Take-Aways Q1 2021

• Q1 2021 good start to accelerate growth:
• • Organic revenue growth in-line with guidance: +3.1% core1 / +3.7% on group level
  • Adj. EBITDA margin core business: 19.0% (+80 basis points yoy)
  • Adj. EPS (FXN) surged +29.3% yoy
• Steep increase in high value solutions: +40% yoy with Biologics growing +50% yoy
• Accelerate growth in the second quarter - guidance confirmed

1. The core business consists of the Plastics & Devices and the Primary Packaging Glass divisions; for adjusted EBITDA purposes also including head office/consolidation.

4

08/04/2021

Q1 2021 Earnings Presentation

One Gerresheimer

One Company With Great Capabilities and Opportunities

− Living One Gerresheimer: we pulled down historical silos and formed a global team committed to our ambitious goals

− Consequent implementation of formula G.

We transform into a growth company as innovation leader and solution provider

P&DPPG

− Focus on customer centricity, excellence, cost efficiency, innovation and sustainability

Gx Biological

Solutions

• Gx Biological Solutions continuously speeding-up

GAT	− Global network of innovation centers:
	bundle knowhow and secure access for the
	whole company

• Build the future: accelerate on smart, intelligent innovations

5

08/04/2021

Q1 2021 Earnings Presentation